SCLX (STOCKS)
Scilex Holding Company Common Stock
$8.260000
-0.300000 (-3.50%)
Prev close: $8.560000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Other
- CEO
- Henry H. Ji
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $70.60M
- Employees
- 31
- P/E (TTM)
- -0.25
- P/B (TTM)
- -0.28
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
0
Strong Buy
0
Buy
3
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2025 (Q2)
|
$-3.79 | $-0.93 | -2.8618 | -308.32% |
|
Mar 2025 (Q1)
|
$-2.26 | $-1.25 | -1.0105 | -80.87% |
|
Dec 2024 (Q4)
|
$0.00 | $-6.96 | +6.9615 | +100.00% |
|
Sep 2024 (Q3)
|
$-1.05 | $-5.95 | +4.9001 | +82.35% |
Financial Statements
| Revenues | $40.36M |
| Benefits Costs and Expenses | $374.75M |
| Cost Of Revenue | $12.68M |
| Costs And Expenses | $374.75M |
| Gross Profit | $27.68M |
| Nonoperating Income/Loss | -$71.09M |
| Operating Expenses | $290.98M |
| Selling, General, and Administrative Expenses | $272.13M |
| Research and Development | $14.72M |
| Operating Income/Loss | -$263.30M |
| Income/Loss From Continuing Operations After Tax | -$334.41M |
| Income/Loss From Continuing Operations Before Tax | -$334.41M |
| Income Tax Expense/Benefit | $19.00K |
| Net Income/Loss | -$334.41M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$334.41M |
| Net Income/Loss Available To Common Stockholders, Basic | -$333.82M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | -$586.00K |
| Preferred Stock Dividends And Other Adjustments | -$586.00K |
| Basic Earnings Per Share | -$19.67 |
| Diluted Earnings Per Share | -$19.72 |
| Basic Average Shares | 131,142,394 |
| Diluted Average Shares | 134,081,394 |
| Assets | $275.88M |
| Current Assets | $16.49M |
| Inventory | $1.08M |
| Other Current Assets | $15.41M |
| Noncurrent Assets | $259.39M |
| Fixed Assets | $703.00K |
| Intangible Assets | $30.42M |
| Other Non-current Assets | $228.27M |
| Liabilities | $455.60M |
| Current Liabilities | $358.95M |
| Accounts Payable | $67.36M |
| Other Current Liabilities | $291.59M |
| Noncurrent Liabilities | $96.65M |
| Equity | -$179.72M |
| Equity Attributable To Noncontrolling Interest | -$2.78M |
| Equity Attributable To Parent | -$176.94M |
| Liabilities And Equity | $275.88M |
| Net Cash Flow From Operating Activities | $23.82M |
| Net Cash Flow From Operating Activities, Continuing | $23.80M |
| Net Cash Flow From Investing Activities | -$895.00K |
| Net Cash Flow From Investing Activities, Continuing | -$895.00K |
| Net Cash Flow From Financing Activities | -$30.16M |
| Net Cash Flow From Financing Activities, Continuing | -$30.16M |
| Net Cash Flow | -$7.27M |
| Net Cash Flow, Continuing | -$7.27M |
| Comprehensive Income/Loss | -$336.07M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$336.07M |
| Other Comprehensive Income/Loss | -$14.30M |